Gross sales of EFT BioTech Holdings crosses $100 million

NewsGuard 100/100 Score

EFT BioTech Holdings, Inc. (PINKSHEETS: EFTB), a business to consumer, on line marketing Company providing "Made in the USA" health, beauty, nutriceutical products along with other goods and services under the EFT brand to its affiliate member network, boasting almost one million registered members strong, reports surpassing $100 million in gross sales since its public listing in November 2007.

Jack Qin, President and CEO, stated, "We are just beginning to implement many of our new expansion plans into new target markets as shown by our recent opening of a member educational office in Seoul, South Korea. More importantly, during the month of August 2009, we have already surpassed $112 million in gross sales since our public listing in November 2007."

George Curry, Vice President of EFT, also commented, "We believe that the Company is now on track for very strong growth over the next few quarters. Typically, the most recent two closing quarters are our slowest period of the year. Assuming history holds true, combined with recent office expansion to attract new affiliate members in different territories, we believe we are positioned for a stellar second half of our fiscal year ending March 2010."

Source:

EFT BioTech Holdings, Inc.

Posted in:

Tags:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.